78.36 M
About Nunzia Pharmaceutical Corporation
Nunzia Pharmaceutical Corp. engages in the manufacture and sales of drugs. It offers Nunzia, a nutraceutical that treats Autism, Fragile X, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PSTD), and other such disorders. The company was founded on November 12, 1986 and is headquartered in Long Beach, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NUNZ is 0.000001 USD — it has decreased by −99.97% in the past 24 hours. Watch Nunzia Pharmaceutical Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Nunzia Pharmaceutical Corporation stocks are traded under the ticker NUNZ.
NUNZ reached its all-time high on Sep 17, 2010 with the price of 9,450.000000 USD, and its all-time low was 0.000001 USD and was reached on Sep 16, 2024. View more price dynamics on NUNZ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NUNZ stock is 299.90 K% volatile and has beta coefficient of 0.00. Track Nunzia Pharmaceutical Corporation stock price on the chart and check out the list of the most volatile stocks — is Nunzia Pharmaceutical Corporation there?
Yes, you can track Nunzia Pharmaceutical Corporation financials in yearly and quarterly reports right on TradingView.
No, NUNZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NUNZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nunzia Pharmaceutical Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nunzia Pharmaceutical Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nunzia Pharmaceutical Corporation stock shows the sell signal. See more of Nunzia Pharmaceutical Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.